Battelle/BIO State Bioscience Initiatives 2010
The bioscience sector has continued to create jobs even in the midst of recession, Battelle/BIO finds in its annual State Bioscience Initiatives report.
12/14/2010
"Not every biotech company made it through the storm. Fifty publicly traded companies went bankrupt for lack of access to capital. But there is much good news. Biotech stocks outperformed virtually every other index in the first quarter of this year. The markets have come back but Biotech has come back faster and stronger," said Jim Greenwood, president and CEO of BIO.
While total private sector employment dropped 0.7 percent from 2007-2008, bioscience employment grew by 1.4 percent. Research, testing, and medical laboratories account for more than 176,000 jobs added from 2001-2008, representing nine of 10 new bioscience jobs created during that time.
States are taking advantage of this growth by investing in major bioscience initiatives; focusing on agricultural biotech and bioenergy; and implementing tax programs favorable to bio companies.
Project Announcements
Siemens Energy Plans Fort Payne, Alabama, Manufacturing Operations
02/09/2026
Preciball USA Plans Screven County, Georgia, Production Operations
02/09/2026
Mecad USA Plans Tulsa Port of Catoosa, Oklahoma, Manufacturing Campus
02/08/2026
Anduril Industries Plans Long Beach-Lakewood, California, Operations
02/08/2026
Dongwon Autopart Technology Plans Emanuel County, Georgia, Production Operations
02/07/2026
Quantum Machines Plans Chicago, Illinois, Operations
02/06/2026
Most Read
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
The New Industrial Revolution in Biotech
Q4 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025